Ectopic Cervical Pregnancy: Treatment Route

Area of Science:

• Reproductive Medicine
• Gynecologic Surgery
• Ectopic Pregnancy Management

Background:

• Cervical pregnancy (CP) is a rare form of ectopic pregnancy (EP) where the embryo implants in the endocervical canal.
• Early diagnosis and treatment are crucial for conservative management and fertility preservation.
• Optimal treatment strategies for CP remain unclear.

Purpose of the Study:

• To evaluate the efficacy of hysteroscopic management for early cervical pregnancy.
• To assess the impact of hysteroscopy on fertility preservation.
• To compare hysteroscopic outcomes with medical management.

Main Methods:

• Retrospective observational case series of five hemodynamically stable patients with CP.
• Four patients with βhCG >5000 mIU/mL were managed with hysteroscopy, with or without prior systemic Methotrexate (MTX).
• One patient with βhCG <5000 mIU/mL received MTX combined with Mifepristone and Misoprostol.

Main Results:

• Hysteroscopy alone in one patient led to significant bleeding requiring a second procedure; other cases had no complications.
• Serum β-hCG levels normalized within 15-40 days after hysteroscopic management and 35 days after medical treatment.
• A faster decline in β-hCG was observed the day after hysteroscopy compared to medical management.
• One patient achieved a spontaneous intrauterine pregnancy five months post-hysteroscopy.

Conclusions:

• Hysteroscopic management, alone or with MTX, is effective for early CP.
• Hysteroscopy demonstrates a more rapid decrease in β-hCG levels, potentially reducing hospitalization and costs.
• Further prospective studies are needed to establish definitive therapeutic protocols for CP.